# Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)

> **NCT04870138** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 16 (actual)

## Conditions studied

- Gonococcal Infection

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Ceftriaxone
- **DRUG:** Ciprofloxacin
- **BIOLOGICAL:** Neisseria gonorrhoeae strain FA1090 A26
- **BIOLOGICAL:** Neisseria gonorrhoeae strain FA7527

## Key facts

- **NCT ID:** NCT04870138
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03-10
- **Primary completion:** 2015-04-28
- **Final completion:** 2015-04-28
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04870138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04870138, "Experimental Human Infection With Neisseria Gonorrhoeae (LptA Trial)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04870138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*